Focal atrial tachycardia (FAT) in patients with structurally normal hearts is an uncommon arrhythmia encountered in clinical practice. The role of ivabradine has not been systematically evaluated in the treatment of FAT.
Patients with incessant FAT (lasting >24 hours) were included in the study.